[1] |
ZHOU Changdong, LIN Yang, SUN Kai, TIAN Yuxin.
Knockdown of lncRNA UCA1 reduces gemcitabine resistance of human bladder cancer cell line T24
[J]. Basic & Clinical Medicine, 2024, 44(8): 1113-1119.
|
[2] |
ZHOU Yue, TONG Anli.
Immune microenvironment of pheochromocytomas and paragangliomas
[J]. Basic & Clinical Medicine, 2024, 44(6): 742-747.
|
[3] |
LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua.
lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
|
[4] |
ZHANG Liangliang, ZHAO Chengjin, ZHOU Yuhu, CAO Bo, DUAN Mingming, FENG Yangyang.
LncRNA FGD5-AS1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by regulating miR-93-5p/BMP2 axis
[J]. Basic & Clinical Medicine, 2023, 43(8): 1179-1185.
|
[5] |
ZHANG Yongmei, ZHANG Zhiming, ZHOU Jie, PAN Zhilan, FENG Liqian, YANG Yan.
Expression and clinical significance of LncRNA CBR3-AS1 in multiple myeloma
[J]. Basic & Clinical Medicine, 2023, 43(6): 948-952.
|
[6] |
YAO Liuxu, LI Yuhong, JIANG Zongming.
Research progress of exosome lncRNA in liquid biopsy of colorectal cancer
[J]. Basic & Clinical Medicine, 2023, 43(2): 317-321.
|
[7] |
YANG Guanglin, REN Lijuan, CHEN Wenjing, XIONG Weijun.
LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223
[J]. Basic & Clinical Medicine, 2023, 43(1): 102-109.
|
[8] |
HUANG Hua, ZHOU Long, YAO Di, XU Yi.
LncRNA PVT1 alleviates inflammation of airway via regulating miR-214/STAT6 axis in mouse models with asthma
[J]. Basic & Clinical Medicine, 2022, 42(9): 1374-1380.
|
[9] |
BAI Bing, ZHANG Hai-fang, YANG Qing-liang, QIN Yue, ZHOU Chen-long, SONG Ge, WANG Ying.
Down-regulation of lncRNA RHPN1-AS1 inhibits proliferation and migration of human bladder cancer cell line T24
[J]. Basic & Clinical Medicine, 2022, 42(6): 940-944.
|
[10] |
XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin.
Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2022, 42(5): 758-762.
|
[11] |
GUO Jing, LI Ya-jie, MOU Han-shuang.
LncRNA FGD5-AS1 reduces ox-LDL-induced damage of HUVECs by targeting miR-106a-5p
[J]. Basic & Clinical Medicine, 2022, 42(5): 768-775.
|
[12] |
LI Zhao-xuan, LUO Yun-ping, CHEN Chong.
Establishment and optimization of air-liquid interface method cultured mouse-derived tumor organoids
[J]. Basic & Clinical Medicine, 2022, 42(5): 782-787.
|
[13] |
ZHANG Jian, ZHANG Ji-jiong.
LncRNA UNC5B-AS1 targeting miR-339-5p regulates the proliferation and apoptosis of human lung adenocarcinoma cell line A549
[J]. Basic & Clinical Medicine, 2022, 42(3): 454-460.
|
[14] |
LIU Ming-sheng, CHEN Wen-chao, CAI Ying-chang.
Down-regulation of lncRNA DNM3OS enhances radiotherapy sensitivity of human rectal cancer cell line SW-480 by targeting miR-193a-3p
[J]. Basic & Clinical Medicine, 2022, 42(2): 260-267.
|
[15] |
WEN Li-na, CHEN Li, DUAN Rui, LI Fang.
Progress of CD8+CD25+regulatory T cells in diseases
[J]. Basic & Clinical Medicine, 2022, 42(12): 1939-1944.
|